Anzeige
Mehr »
Mittwoch, 17.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
244 Leser
Artikel bewerten:
(1)

Neurovations: 30 Years of Groundbreaking Medical Education Features Award-Winning Speakers

CEO and Founder of Neurovations Dr. Eric Grigsby Celebrates Three Decades of Innovation in Chronic Pain Management at 30th Napa Pain Conference

NAPA, CA / ACCESSWIRE / September 12, 2023 / The 30th Napa Pain Conference concluded on Aug. 20, 2023, celebrating three decades of unwavering commitment to advancing treatments and research for pain and neurological disease. The conference brought together global experts, researchers, clinicians, and healthcare professionals who shared groundbreaking insights in the field of pain medicine.

Napa Pain Conference

Napa Pain Conference

Nobel Prize recipient Dr. Carolyn Bertozzi delivered the 2023 Lindahl Lecture. Renowned for her groundbreaking research in the field of chemical biology, coining the term and field of bioorthogonal chemistry, Professor Bertozzi has been the recipient of honors of the highest scientific order, including a MacArthur Fellowship and the Breakthrough Prize in Life Sciences, as well as the 2022 Nobel Prize in Chemistry.

"Dr. Bertozzi's keynote session on her work with cancer cells was quite simply one of the best sessions I have ever attended. She has a unique and brilliant mind, and a gift for collaboration and mentorship," said Dr. Eric Grigsby, founder and CEO of Neurovations, a patient care and innovation company.

The Lindahl Lecture is named for Dr. Grigsby's early mentor Dr. Sten Lindahl, former Chair of the Nobel Committee. Past Lindahl Lectures include Bruce Beutler, MD, 2011 Nobel Prize recipient in Medicine, and Jennifer Doudna, PhD, Nobel Prize recipient in 2020 and developer of CRISPR technology.

The conference also honored Dr. Lawrence Poree with the inaugural Dr. Elliot Krames Award for Excellence in Translational Neuromodulation and Dr. Peter Staats, Chief Medical Officer, National Spine and Pain Centers, who presented the Legacy Lecture for dedication to the field of chronic pain.

"I am truly honored to have been chosen to deliver the Legacy Lecture at the 30th Napa Pain Conference. It's a testament to the dedication and collaborative spirit of all those who have contributed to this journey. I am reminded of the challenges we've overcome and the breakthroughs that have transformed patient care. This legacy fuels our determination to continue pushing the boundaries of pain research and treatment, ensuring a brighter and pain-free future for all," Dr. Staats said.

The annual vineyard dinner was held at the Grigsby Vineyard in Yountville, marking the occasion for the inaugural release of the Grigsby Vineyard Cabernet Sauvignon and Petit Syrah.

"The Grigsby family's legacy dates to 1846 when our forebear John Grigsby first cultivated this land. Today, we honor his pioneering spirit with organic farming and a goal to produce the finest wine the land will give us. I can't think of a better way to launch Grigsby Vineyard than to share it with this incredible group," Dr. Grigsby said.

Experts in the field of interventional pain medicine presented Dr. Grigsby with an award recognizing his dedication to innovation in the field of chronic pain management. The award, which featured a video of well-wishers from across the globe, was presented by Dr. Grigsby's own daughter Giovanna Grigsby, currently enrolled in medical school at Mayo Clinic.

"I was overwhelmed by the kindness from those I respect so much. To hear doctors Carol Warfield, Daniel Carr and Elliott Krames - just to name a few - say such kind things about the past 30 years of work, was humbling. The success of the conference underscores its significance as a pivotal platform for advancing pain management knowledge and practices. As the field continues to evolve, the Napa Pain Conference remains committed to driving innovation, fostering interdisciplinary cooperation, and improving the lives of those living with pain."

Contact Information

Krista Clark
Marketing Director
krista@neurovations.com
7072529665

Related Video

https://www.youtube.com/watch?v=yHcxU5VxXXo

SOURCE: Neurovations

.

View source version on accesswire.com:
https://www.accesswire.com/782910/30-years-of-groundbreaking-medical-education-features-award-winning-speakers

© 2023 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.